VYNE Therapeutics Inc (VYNE)

[realfast95]

Stock analysts at Piper Sandler decreased their Q2 2020 earnings estimates for Menlo Therapeutics in a research report issued to clients and investors on Monday, May 11th. Piper Sandler analyst D. Amsellem now forecasts that the company will post earnings of ($0.18) per share for the quarter, down from their previous estimate of ($0.11). Piper Sandler also issued estimates for Menlo Therapeutics’ Q3 2020 earnings at ($0.18) EPS, Q4 2020 earnings at ($0.14) EPS, FY2020 earnings at ($0.79) EPS, Q1 2021 earnings at ($0.12) EPS, Q2 2021 earnings at ($0.08) EPS, Q3 2021 earnings at ($0.08) EPS, Q4 2021 earnings at ($0.05) EPS, FY2021 earnings at ($0.33) EPS and FY2022 earnings at $0.03 EPS.

https://www.dispatchtribunal.com/2020/05/15/piper-sandler-brokers-cut-earnings-estimates-for-menlo-therapeutics-inc-nasdaqmnlo.html


Menlo Therapeutics Inc (NASDAQ:MNLO) – Research analysts at Piper Sandler lowered their FY2023 earnings per share estimates for Menlo Therapeutics in a note issued to investors on Monday, May 11th. Piper Sandler analyst D. Amsellem now forecasts that the company will post earnings of $0.21 per share for the year, down from their previous estimate of $0.22.

https://www.themarketsdaily.com/2020/05/15/piper-sandler-weighs-in-on-menlo-therapeutics-incs-fy2023-earnings-nasdaqmnlo.html